文献速递中医内科针灸推拿

经皮耳迷走神经刺激治疗功能性消化不良的系统评价与Meta分析

Transcutaneous auricular vagus nerve stimulation for functional dyspepsia: A systematic review and meta-analysis.
PubMed 文献 · Complement Ther Med · 2025-09-16

该系统评价与Meta分析纳入6项随机对照试验共716例功能性消化不良患者,评估经皮耳迷走神经刺激(taVNS)的疗效。结果显示,与假刺激相比,taVNS可显著改善消化不良症状、生活质量及焦虑抑郁,总有效率更高,且无严重不良事件。证据确定性为中等至高,提示taVNS可能是一种有效的非侵入性治疗,但需更多高质量研究确定最佳方案。

要点

  • taVNS可显著改善FD患者的消化不良症状、生活质量及焦虑抑郁,证据确定性中等。
  • taVNS的总有效率显著高于对照,证据确定性高。
  • 常见刺激部位为耳甲腔和耳屏,频率25或20 Hz,每日两次,疗程2-4周。

核心结论

  • 基于中等至高质量证据,taVNS可改善FD患者的消化不良症状、生活质量、焦虑和抑郁,且无严重不良事件。

研究设计与样本

  • 系统评价与Meta分析,检索8个数据库至2024年6月27日,纳入6项RCT共716例FD患者。

主要发现

  • 与假刺激相比,taVNS显著改善消化不良症状、生活质量及临床医生评定的焦虑抑郁,证据确定性中等。
  • 基于消化不良症状的总有效率在taVNS组显著更高,证据确定性高。
  • taVNS作为附加治疗时,消化不良症状显著改善,证据确定性中等。
  • 未报告与taVNS相关的严重不良事件。

关键数值与推荐

  • 刺激部位为耳甲腔和耳屏,常见脉冲频率为25或20 Hz,每日两次,疗程2-4周。
  • 通过胃容受性、胃电图、心率变异性及功能磁共振成像探索taVNS机制。

临床怎么用

  • 对于FD患者,可考虑使用taVNS作为非侵入性治疗,刺激耳甲腔或耳屏,频率25或20 Hz,每日两次,疗程2-4周。
  • taVNS可单独或作为附加治疗使用,需监测不良事件,但严重事件罕见。

局限性

  • 需要更多高质量研究来确定最佳治疗方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transcutaneous auricular vagus nerve stimulation (taVNS) is a potential noninvasive treatment for functional dyspepsia (FD). We aimed to systematically analyze the clinical evidence of taVNS for FD. METHODS: Eight databases were searched to identify randomized controlled trials (RCTs) using taVNS in patients with FD published by June 27, 2024. The primary outcome was dyspepsia symptoms, whereas the secondary outcomes were the total effective rate (TER), quality of life, anxiety, depression, and incidence of adverse events. The certainty of the evidence was assessed using the GRADE methodology. Detailed information on the taVNS parameters and the suggested underlying mechanism were also extracted. RESULTS: Six RCTs with 716 participants were included. Compared to the sham intervention, taVNS significantly improved dyspepsia symptoms, quality of life, and clinician-rated anxiety and depression with moderate certainty of evidence. The TER based on dyspepsia symptoms was also significantly higher with high certainty of evidence. When taVNS was used as an add-on therapy, dyspepsia symptoms were significantly improved with moderate certainty of evidence. No serious adverse events related to taVNS were reported. The stimulation sites for taVNS were concha and tragus, with common pulse frequencies of 25 or 20 Hz twice a day for 2-4 weeks. Gastric accommodation, electrogastrogram, heart rate variability, and functional magnetic resonance imaging were measured to explore the mechanism of taVNS. CONCLUSIONS: Considering the certainty of the evidence, taVNS can improve dyspepsia symptoms, quality of life, anxiety, and depression in patients with FD without serious adverse events. Additional high-quality studies are needed to establish optimal treatment protocols.

来源:Complement Ther Med,查看原文。版权归原作者所有。

引用

  1. Lee B, Kwon CY, Jeong YK, et al. Transcutaneous auricular vagus nerve stimulation for functional dyspepsia: A systematic review and meta-analysis. Complement Ther Med. 2025. PMID: 40967422. doi:10.1016/j.ctim.2025.103243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。